IRIS Accounts Production v25.4.0.155 10129044 Board of Directors 1.5.23 31.10.24 31.10.24 true false true true false false true false A Ordinary 1.00000 B Ordinary 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 10129044 2023-04-30 10129044 2024-10-31 10129044 2023-05-01 2024-10-31 10129044 2022-04-30 10129044 2022-05-01 2023-04-30 10129044 2023-04-30 10129044 ns15:EnglandWales 2023-05-01 2024-10-31 10129044 ns14:PoundSterling 2023-05-01 2024-10-31 10129044 ns10:Director1 2023-05-01 2024-10-31 10129044 ns10:PrivateLimitedCompanyLtd 2023-05-01 2024-10-31 10129044 ns10:FRS102 2023-05-01 2024-10-31 10129044 ns10:Audited 2023-05-01 2024-10-31 10129044 ns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport 2023-05-01 2024-10-31 10129044 ns10:LargeMedium-sizedCompaniesRegimeForAccounts 2023-05-01 2024-10-31 10129044 ns10:FullAccounts 2023-05-01 2024-10-31 10129044 ns10:OrdinaryShareClass2 2023-05-01 2024-10-31 10129044 ns10:OrdinaryShareClass3 2023-05-01 2024-10-31 10129044 ns10:Director2 2023-05-01 2024-10-31 10129044 ns10:RegisteredOffice 2023-05-01 2024-10-31 10129044 ns5:CurrentFinancialInstruments 2024-10-31 10129044 ns5:CurrentFinancialInstruments 2023-04-30 10129044 ns5:ShareCapital 2024-10-31 10129044 ns5:ShareCapital 2023-04-30 10129044 ns5:RetainedEarningsAccumulatedLosses 2024-10-31 10129044 ns5:RetainedEarningsAccumulatedLosses 2023-04-30 10129044 ns5:ShareCapital 2022-04-30 10129044 ns5:RetainedEarningsAccumulatedLosses 2022-04-30 10129044 ns5:ShareCapital 2022-05-01 2023-04-30 10129044 ns5:RetainedEarningsAccumulatedLosses 2022-05-01 2023-04-30 10129044 ns5:RetainedEarningsAccumulatedLosses 2023-05-01 2024-10-31 10129044 ns5:FurnitureFittings 2023-05-01 2024-10-31 10129044 ns5:MotorVehicles 2023-05-01 2024-10-31 10129044 ns5:ComputerEquipment 2023-05-01 2024-10-31 10129044 ns5:OwnedAssets 2023-05-01 2024-10-31 10129044 ns5:OwnedAssets 2022-05-01 2023-04-30 10129044 1 2023-05-01 2024-10-31 10129044 1 2022-05-01 2023-04-30 10129044 2 2023-05-01 2024-10-31 10129044 2 2022-05-01 2023-04-30 10129044 ns10:OrdinaryShareClass2 2022-05-01 2023-04-30 10129044 ns10:OrdinaryShareClass3 2022-05-01 2023-04-30 10129044 ns5:FurnitureFittings 2024-10-31 10129044 ns5:MotorVehicles 2024-10-31 10129044 ns5:ComputerEquipment 2024-10-31 10129044 ns5:CurrentFinancialInstruments ns5:WithinOneYear 2024-10-31 10129044 ns5:CurrentFinancialInstruments ns5:WithinOneYear 2023-04-30 10129044 ns10:OrdinaryShareClass2 2024-10-31 10129044 ns10:OrdinaryShareClass3 2024-10-31 10129044 ns5:RetainedEarningsAccumulatedLosses 2023-04-30 10129044 1 ns10:Director1 2023-04-30 10129044 1 ns10:Director1 2022-04-30 10129044 1 ns10:Director1 2023-05-01 2024-10-31 10129044 1 ns10:Director1 2022-05-01 2023-04-30 10129044 1 ns10:Director1 2024-10-31 10129044 1 ns10:Director1 2023-04-30

REGISTERED NUMBER: 10129044 (England and Wales)

| STRATEGIC REPORT, REPORT OF THE DIRECTORS AND |

| FINANCIAL STATEMENTS |

| FOR THE PERIOD 1 MAY 2023 TO 31 OCTOBER 2024 |

| FOR |

| MEDICAL STAFFING SOLUTIONS LIMITED |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

CONTENTS OF THE FINANCIAL STATEMENTS

for the period 1 May 2023 to 31 October 2024

Page |

| Company Information | 1 |

| Strategic Report | 2 |

| Report of the Directors | 4 |

| Report of the Independent Auditors | 6 |

| Income Statement | 10 |

| Other Comprehensive Income | 11 |

| Balance Sheet | 12 |

| Statement of Changes in Equity | 13 |

| Cash Flow Statement | 14 |

| Notes to the Cash Flow Statement | 15 |

| Notes to the Financial Statements | 16 |

| MEDICAL STAFFING SOLUTIONS LIMITED |

COMPANY INFORMATION

for the period 1 May 2023 to 31 October 2024

| DIRECTORS: | Mrs L Eastwell

| Mr I Eastwell

| REGISTERED OFFICE: | Rydal Mount

| North Road

| Havering-Atte-Bower

| Romford

| Essex

| RM4 1QA

| REGISTERED NUMBER: | 10129044 (England and Wales)

| AUDITORS: | Xeinadin Audit Limited Chartered Accountants

| Statutory Auditor

| 8th Floor, Becket House

| 36 Old Jewry

| London

| EC2R 8DD

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

STRATEGIC REPORT

for the period 1 May 2023 to 31 October 2024

The directors present their strategic report for the period 1 May 2023 to 31 October 2024.

REVIEW OF BUSINESS

The result for the period is shown on page 10. As shown in the company's profit and loss account, the company's operating profit for continuing operations for the period was £1,953,214 (2023 - £525,630).

The company's balance sheet on page 12 shows net assets of £1,752,853 (2023 - £297,336) at the period of the year, with a cash position of £1,046,224 (2023 - £512,595).

The 2024 financial period was one of growth, with the commencement of new NHS contracts. The company has continued to expand since the balance sheet date with further new long term contracts agreed.

The company retained key framework agreements and client relationships which enabled it to position itself within the market leaders in its sector.

PRINCIPAL RISKS AND UNCERTAINTIES

The company's operations expose it to a variety of financial risks that include the effects of changes in credit risk, liquidity risk and interest rate risk. The company has in place a risk management programme that seeks to limit the adverse effects on the financial performance of the company monitoring levels of debt finance and the related finance costs. The company does not use derivative financial instruments to manage interest rate costs and as such, no hedge accounting is applied.

Given the size of the company, the directors have not delegated the responsibility of monitoring financial risk management to a sub-committee of the board. The policies set by the board of directors are implemented by the company's finance department.

Price risk

The company is exposed to price risk due to normal inflationary increases in the purchase price of the services purchased in the UK. The company has no exposure to equity securities price risk as it holds no listed or other equity investments.

Liquidity risk

The company actively maintains short-term debt finance that is designed to ensure that the company has sufficient available funds for operations and planned expansions.

Interest rate risk

The company has interest bearing liabilities. The company has a policy of maintaining debt at a fixed rate to ensure certainty of future interest cash flows. The directors will revisit the appropriateness of this policy if the operations of the company change in size or nature.

ENGAGEMENT WITH EMPLOYEES

The company operates an equal opportunities policy. The aim of this policy is to ensure that there should be equal opportunity for all and this applies to external recruitment, internal appointments, terms of employment, conditions of service and opportunity for training and promotion regardless of gender, ethnic origin or disability.

Disabled persons are given full and fair consideration for all types of vacancy in as much as the opportunities available are constrained by the practical limitations of the disability. Should, for whatever reason, an employee of the group becomes disabled whilst in the employment, every step, where appropriate will be taken to assist with rehabilitation and suitable re-training.

The company maintains its own health, safety and environmental policies covering all aspect of its operations. Regular meetings and inspections take place to ensure all legal requirements are adhered to and that the company is responsive to the needs of the employees and the environment.

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

STRATEGIC REPORT

for the period 1 May 2023 to 31 October 2024

CORPORATE SOCIAL RESPONSIBILITY

- Health and safety policy and performance is monitored and updated on an annual basis.

- The company delivers specialist recruitment services and ensures that competent and qualified people are selected.

- Other examples of polices implemented by the company in order to comply with the spirit of the law and maintain the ethical standards are: equal opportunities, harassment, training and career development.

KEY PERFORMANCE INDICATORS

- Customer satisfaction and retention - has improved over the years especially considering the relationships developed with our existing client base which is reflected in the increase in new contracts with existing customers.

- Employee Satisfaction - maintaining of staff morale has been a key factor in the company's growth. The company has introduced measures to evaluate and improve employee satisfaction.

- Gross profit margin - margin has improved on the prior years due to constant monitoring and introduction of efficiencies and negotiating higher rates.

| 2024 |  |  | 2023 |  | Measure |

Gross profit margin |  | 11.68% |  |  | 10.38% |  | Gross profit/turnover |

- Debtor days - debtor days have decreased which has helped the company to maintain a healthy cash position and maintain debtors days as low as possible.

| 2024 |  |  | 2023 |  | Measure |

Debtor days |  | 46 days |  |  | 66 days |  | Trade debtors/turnover |

ON BEHALF OF THE BOARD:

Mrs L Eastwell - Director

9 February 2026

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

REPORT OF THE DIRECTORS

for the period 1 May 2023 to 31 October 2024

The directors present their report with the financial statements of the company for the period 1 May 2023 to 31 October 2024.

PRINCIPAL ACTIVITY

The principal activity of the company in the period under review was that of a recruitment agency.

DIVIDENDS

No dividends will be distributed for the period ended 31 October 2024.

FUTURE DEVELOPMENTS

Please refer to the Strategic Report.

DIRECTOR

Mrs L Eastwell held office during the whole of the period from 1 May 2023 to the date of this report.

Other changes in directors holding office are as follows:

Mr I Eastwell was appointed as a director after 31 October 2024 but prior to the date of this report.

POLITICAL DONATIONS AND EXPENDITURE

The company did not make any political donations during the current year nor the previous year.

ASSESSMENT OF GOING CONCERN

The directors have assessed whether the use of the going concern assumption is appropriate in preparing these accounts. They have made this assessment in respect to a period of one year from the date of approval of these accounts.

The directors have carefully considered the impact of the macroeconomic uncertainties on the company's financial position, liquidity and future performance. As set out in the strategic report, the company has continued to trade strongly throughout this period and the directors believe that it is experiencing good levels of sales growth and profitability. Therefore, the directors believe that the company is well placed to manage its business risks successfully.

Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. They have concluded that there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the company to continue as a going concern.

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- | select suitable accounting policies and then apply them consistently;

- | make judgements and accounting estimates that are reasonable and prudent;

- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

REPORT OF THE DIRECTORS

for the period 1 May 2023 to 31 October 2024

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

ON BEHALF OF THE BOARD:

Mrs L Eastwell - Director

9 February 2026

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF

MEDICAL STAFFING SOLUTIONS LIMITED

Opinion

We have audited the financial statements of Medical Staffing Solutions Limited (the 'company') for the period ended 31 October 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

- | give a true and fair view of the state of the company's affairs as at 31 October 2024 and of its profit for the period then ended;

- | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- | have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

- | the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- | the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF

MEDICAL STAFFING SOLUTIONS LIMITED

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

- | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

- | the financial statements are not in agreement with the accounting records and returns; or

- | certain disclosures of directors' remuneration specified by law are not made; or

- | we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF

MEDICAL STAFFING SOLUTIONS LIMITED

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

- the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;

- we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the healthcare sector;

- we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006, taxation legislation and data protection, employment, and health and safety legislation and NHS Framework requirements;

- we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence where necessary.

We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and

- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:

- performed analytical procedures to identify any unusual or unexpected transactions;

- performing substantive work of material areas affecting profit and revenue recognition;

- tested the appropriateness of journal entries;

- tested authorisation of expenditure;

- assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias; and

- investigated the rationale behind significant or unusual transactions.

To address the risk that revenue could be misstated due to fraud, we:

- we obtained an understanding of the company's revenue recognition policies and compared these to the accounting standard;

- performed a walkthrough to confirm our understanding of the processes and controls through which the business initiates, records, processes and reports revenue transactions;

- tested a sample of revenue transactions to supporting evidence; and

- tested, on a sample basis, revenue related balances in the balance sheet.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

- agreeing financial statement disclosures to underlying supporting documentation;

- reading the minutes of meetings of those charged with governance;

- enquiring of management as to actual and potential litigation and claims; and

- reviewing correspondence with HMRC, relevant regulators, and the company's legal advisors.

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF

MEDICAL STAFFING SOLUTIONS LIMITED

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Other matters we are required to address

The financial statements of the company for the year ended 30 April 2023 were not audited, as an exemption from audit was claimed under s.382 of the Companies Act 2006.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Mr Adam Moody FCCA (Senior Statutory Auditor)

for and on behalf of Xeinadin Audit Limited Chartered Accountants

Statutory Auditor

8th Floor, Becket House

36 Old Jewry

London

EC2R 8DD

10 February 2026

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

INCOME STATEMENT

for the period 1 May 2023 to 31 October 2024

| Period |

| 1.5.23 |

| to |  | Year Ended

| 31.10.24 |  | 30.4.23

| Notes | £ | £ |

TURNOVER | 3 | 32,263,681 |  | 14,008,875 |  |

Cost of sales | (28,495,077 | ) | (12,555,409 | ) |

GROSS PROFIT | 3,768,604 |  | 1,453,466 |  |

Administrative expenses | (1,493,944 | ) | (809,634 | ) |

OPERATING PROFIT | 5 | 2,274,660 |  | 643,832 |  |

Interest payable and similar expenses | 6 | (340,446 | ) | (126,595 | ) |

PROFIT BEFORE TAXATION | 1,934,214 |  | 517,237 |  |

Tax on profit | 7 | (478,697 | ) | (120,851 | ) |

PROFIT FOR THE FINANCIAL PERIOD | 1,455,517 |  | 396,386 |  |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

OTHER COMPREHENSIVE INCOME

for the period 1 May 2023 to 31 October 2024

| Period |

| 1.5.23 |

| to |  | Year Ended

| 31.10.24 |  | 30.4.23

| Notes | £ | £ |

PROFIT FOR THE PERIOD | 1,455,517 |  | 396,386 |  |

OTHER COMPREHENSIVE INCOME | - |  | - |  |

TOTAL COMPREHENSIVE INCOME FOR THE PERIOD | 1,455,517 |  | 396,386 |  |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

BALANCE SHEET

31 October 2024

| 2024 | 2023 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 9 | 98,692 |  | - |  |

CURRENT ASSETS

Debtors | 10 | 5,608,173 |  | 2,890,914 |  |

Cash at bank and in hand | 1,046,224 |  | 512,595 |  |

6,654,397 |  | 3,403,509 |  |

CREDITORS

Amounts falling due within one year | 11 | 5,000,236 |  | 3,106,173 |  |

NET CURRENT ASSETS | 1,654,161 |  | 297,336 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 1,752,853 |  | 297,336 |  |

CAPITAL AND RESERVES

Called up share capital | 13 | 2 |  | 2 |  |

Retained earnings | 14 | 1,752,851 |  | 297,334 |  |

SHAREHOLDERS' FUNDS | 1,752,853 |  | 297,336 |  |

The financial statements were approved by the Board of Directors and authorised for issue on 9 February 2026 and were signed on its behalf by:

Mrs L Eastwell - Director

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

STATEMENT OF CHANGES IN EQUITY

for the period 1 May 2023 to 31 October 2024

| Called up |

| share |  | Retained |  | Total

| capital |  | earnings |  | equity

£ | £ | £ |

Balance at 1 May 2022 | 1 |  | 124,756 |  | 124,757 |  |

Changes in equity

Issue of share capital | 1 |  | - |  | 1 |  |

Dividends | - |  | (223,808 | ) | (223,808 | ) |

Total comprehensive income | - |  | 396,386 |  | 396,386 |  |

Balance at 30 April 2023 | 2 |  | 297,334 |  | 297,336 |  |

Changes in equity

Total comprehensive income | - |  | 1,455,517 |  | 1,455,517 |  |

Balance at 31 October 2024 | 2 |  | 1,752,851 |  | 1,752,853 |  |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

CASH FLOW STATEMENT

for the period 1 May 2023 to 31 October 2024

| Period |

| 1.5.23 |

| to |  | Year Ended

| 31.10.24 |  | 30.4.23

| Notes | £ | £ |

Cash flows from operating activities

Cash generated from operations | 1 | 2,107,094 |  | 705,306 |  |

Interest paid | (340,446 | ) | (126,595 | ) |

Tax paid | (163,256 | ) | 1,413 |  |

Net cash from operating activities | 1,603,392 |  | 580,124 |  |

Cash flows from investing activities

Purchase of tangible fixed assets | (127,619 | ) | - |  |

Net cash from investing activities | (127,619 | ) | - |  |

Cash flows from financing activities

Amount withdrawn by directors | (942,144 | ) | (6,528 | ) |

Share issue | - |  | 1 |  |

Equity dividends paid | - |  | (223,808 | ) |

Net cash from financing activities | (942,144 | ) | (230,335 | ) |

Increase in cash and cash equivalents | 533,629 |  | 349,789 |  |

Cash and cash equivalents at beginning of period | 2 | 512,595 |  | 162,806 |  |

Cash and cash equivalents at end of period | 2 | 1,046,224 |  | 512,595 |  |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

NOTES TO THE CASH FLOW STATEMENT

for the period 1 May 2023 to 31 October 2024

1. | RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

| Period |

| 1.5.23 |

| to | Year Ended

| 31.10.24 |  | 30.4.23

£ | £ |

| Profit before taxation | 1,934,214 |  | 517,237 |  |

| Depreciation charges | 28,927 |  | - |  |

| Finance costs | 340,446 |  | 126,595 |  |

2,303,587 |  | 643,832 |  |

| Increase in trade and other debtors | (1,775,115 | ) | (898,003 | ) |

| Increase in trade and other creditors | 1,578,622 |  | 959,477 |  |

| Cash generated from operations | 2,107,094 |  | 705,306 |  |

2. | CASH AND CASH EQUIVALENTS

| The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

| Period ended 31 October 2024

| 31.10.24 |  | 1.5.23

£ | £ |

| Cash and cash equivalents | 1,046,224 |  | 512,595 |  |

| Year ended 30 April 2023

| 30.4.23 |  | 1.5.22

£ | £ |

| Cash and cash equivalents | 512,595 |  | 162,806 |  |

3. | ANALYSIS OF CHANGES IN NET FUNDS

| At 1.5.23 | Cash flow | At 31.10.24

£ | £ | £ |

| Net cash |

| Cash at bank and in hand | 512,595 |  | 533,629 |  | 1,046,224 |  |

512,595 |  | 533,629 |  | 1,046,224 |  |

| Total | 512,595 |  | 533,629 |  | 1,046,224 |  |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

NOTES TO THE FINANCIAL STATEMENTS

for the period 1 May 2023 to 31 October 2024

1. | STATUTORY INFORMATION

| Medical Staffing Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Assessment of going concern

| The directors have assessed whether the use of the going concern assumption is appropriate in preparing these accounts. The directors have made this assessment in respect to a period of one year from the date of approval of these accounts.

| The directors have concluded that there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the group to continue as a going concern. The directors are of the opinion that the company will have sufficient resources to meet its liabilities as they fall due.

| Critical accounting judgements

| The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the company's accounting policies.

| The items in the accounts where these judgements and estimates have been made, include:

| - estimating the useful economic life of tangible fixed assets for the purpose of calculating the depreciation charge;

| - assessing the recoverability of outstanding debtors;

| - estimating future income and expenditure flows for the purpose of assessing the company’s going concern.

| Turnover

| Turnover represents net invoiced sales of services, excluding value added tax.Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.

| Contract revenue is recognised based on the number of contractor hours worked multiplied by the agreed hourly rate. Revenue not invoiced by the end of the period is accrued within debtors.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Fixtures and fittings | - | 15% on reducing balance

| Motor vehicles | - | 25% on reducing balance

| Computer equipment | - | 33% on cost

| Taxation

| Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

NOTES TO THE FINANCIAL STATEMENTS - continued

for the period 1 May 2023 to 31 October 2024

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| Financial instruments

| Basic financial assets, including trade and other receivables and cash and bank balances are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

| Such assets are subsequently carried at amortised cost using the effective interest method.

| Basic financial liabilities, including trade and other payables, bank loans, that are classified as debt, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

3. | TURNOVER

| The turnover and profit before taxation are attributable to the one principal activity of the company.

| Turnover relates to income derived from the UK only.

4. | EMPLOYEES AND DIRECTORS

| Period |

| 1.5.23 |

| to | Year Ended

| 31.10.24 |  | 30.4.23

£ | £ |

| Wages and salaries | 9,319,991 |  | 5,240,686 |  |

| Social security costs | 1,068,370 |  | 631,086 |  |

| Other pension costs | 112,194 |  | 51,595 |  |

10,500,555 |  | 5,923,367 |  |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

NOTES TO THE FINANCIAL STATEMENTS - continued

for the period 1 May 2023 to 31 October 2024

4. | EMPLOYEES AND DIRECTORS - continued

| The average number of employees during the period was as follows:

| Period |

| 1.5.23 |

| to | Year Ended

| 31.10.24 |  | 30.4.23

| Sales and administration | 6 |  | 5 |  |

| Nursing | 280 |  | 115 |  |

| Management | 2 |  | 1 |  |

288 |  | 121 |  |

| Period |

| 1.5.23 |

| to | Year Ended

| 31.10.24 |  | 30.4.23

£ | £ |

| Directors' remuneration | 13,644 |  | 18,192 |  |

5. | OPERATING PROFIT

| The operating profit is stated after charging:

| Period |

| 1.5.23 |

| to | Year Ended

| 31.10.24 |  | 30.4.23

£ | £ |

| Depreciation - owned assets | 28,927 |  | - |  |

| Auditors' remuneration | 42,000 |  | - |  |

6. | INTEREST PAYABLE AND SIMILAR EXPENSES |

| Period |

| 1.5.23 |

| to | Year Ended

| 31.10.24 |  | 30.4.23

£ | £ |

| Interest on late tax payment | 18,999 |  | 8,393 |  |

| Invoice discounting interest | 321,447 |  | 118,202 |  |

340,446 |  | 126,595 |  |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

NOTES TO THE FINANCIAL STATEMENTS - continued

for the period 1 May 2023 to 31 October 2024

7. | TAXATION

| Analysis of the tax charge

| The tax charge on the profit for the period was as follows:

| Period |

| 1.5.23 |

| to | Year Ended

| 31.10.24 |  | 30.4.23

£ | £ |

| Current tax:

| UK corporation tax | 478,697 |  | 120,851 |  |

| Tax on profit | 478,697 |  | 120,851 |  |

| Reconciliation of total tax charge included in profit and loss

| The tax assessed for the period is lower than the standard rate of corporation tax in the UK. The difference is explained below:

| Period |

| 1.5.23 |

| to | Year Ended

| 31.10.24 |  | 30.4.23

£ | £ |

| Profit before tax | 1,934,214 |  | 517,237 |  |

| Profit multiplied by the standard rate of corporation tax in the UK of 25% (2023 - 19.490%) | 483,554 |  | 100,809 |  |

| Effects of:

| Expenses not deductible for tax purposes | 7,794 |  | 20,042 |  |

| Capital allowances in excess of depreciation | (12,651 | ) | - |  |

| Total tax charge | 478,697 |  | 120,851 |  |

8. | DIVIDENDS

| Period |

| 1.5.23 |

| to | Year Ended

| 31.10.24 |  | 30.4.23

£ | £ |

| A Ordinary share of £1 |

| Interim | - |  | 111,904 |  |

| B Ordinary share of £1 |

| Interim | - |  | 111,904 |  |

- |  | 223,808 |  |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

NOTES TO THE FINANCIAL STATEMENTS - continued

for the period 1 May 2023 to 31 October 2024

9. | TANGIBLE FIXED ASSETS

| Fixtures |

| and |  | Motor |  | Computer |

| fittings |  | vehicles |  | equipment |  | Totals

£ | £ | £ | £ |

| COST

| Additions | 74,059 |  | 52,758 |  | 802 |  | 127,619 |  |

| At 31 October 2024 | 74,059 |  | 52,758 |  | 802 |  | 127,619 |  |

| DEPRECIATION

| Charge for period | 12,406 |  | 16,211 |  | 310 |  | 28,927 |  |

| At 31 October 2024 | 12,406 |  | 16,211 |  | 310 |  | 28,927 |  |

| NET BOOK VALUE

| At 31 October 2024 | 61,653 |  | 36,547 |  | 492 |  | 98,692 |  |

10. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2024 | 2023 |

£ | £ |

| Trade debtors | 4,100,087 |  | 2,520,309 |  |

| Other debtors | 47,965 |  | 23,481 |  |

| Directors' current accounts | 942,144 |  | - |  |

| Prepayments and accrued income | 517,977 |  | 347,124 |  |

5,608,173 |  | 2,890,914 |  |

11. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2024 | 2023 |

£ | £ |

| Tax | 478,697 |  | 163,256 |  |

| Social security and other taxes | 728,806 |  | 254,192 |  |

| Other creditors | 3,414,929 |  | 2,467,134 |  |

| Accrued expenses | 377,804 |  | 221,591 |  |

5,000,236 |  | 3,106,173 |  |

12. | SECURED DEBTS

| The following secured debts are included within creditors:

2024 | 2023 |

£ | £ |

| Invoice discounting facility | 3,002,190 |  | 2,159,225 |  |

| The invoice discounting facility with Bibby is secured by a fixed charge and a floating charge over all property owned by the company.

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

NOTES TO THE FINANCIAL STATEMENTS - continued

for the period 1 May 2023 to 31 October 2024

13. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2024 | 2023 |

| value: | £ | £ |

| 1 | A Ordinary | £1 | 1 |  | 1 |  |

| 1 | B Ordinary | £1 | 1 |  | 1 |  |

2 |  | 2 |  |

14. | RESERVES

| Retained

| earnings

£ |

| At 1 May 2023 | 297,334 |  |

| Profit for the period | 1,455,517 |  |

| At 31 October 2024 | 1,752,851 |  |

15. | PENSION COMMITMENTS

| The company operates a defined contribution scheme. The assets of the scheme are held separately from those of the company, being invested with an insurance company. During the year contributions payable by the company to the fund amounted to £112,194 (2023 - £51,552). There were no prepaid or accrued contributions at 31 October 2024 or 30 April 2023.

16. | CONTINGENT LIABILITIES

| There were no contingent liabilities at either the beginning or end of the financial year.

17. | CAPITAL COMMITMENTS

| At 31 October 2024 and 30 April 2023 the company had no capital commitments which had been contracted for but not provided in the financial statements.

18. | DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to a director subsisted during the period ended 31 October 2024 and the year ended 30 April 2023:

2024 | 2023 |

£ | £ |

| Mrs L Eastwell

| Balance outstanding at start of period | - |  | (6,528 | ) |

| Amounts advanced | 942,144 |  | 230,336 |  |

| Amounts repaid | - |  | (223,808 | ) |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of period | 942,144 |  | - |  |

MEDICAL STAFFING SOLUTIONS LIMITED (REGISTERED NUMBER: 10129044) |

NOTES TO THE FINANCIAL STATEMENTS - continued

for the period 1 May 2023 to 31 October 2024

19. | RELATED PARTY DISCLOSURES

| At the balance sheet date, the company owed £278,923 (2023 - £224,646) to Vitality Staffing Ltd, a company connected by virtue of common control.

20. | ULTIMATE CONTROLLING PARTY

| The controlling party is Mrs L Eastwell.